Tural, D. Et Al. 2016. Receptor discordance after neoadjuvant chemotherapy and its impact on disease-free survival.. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , (Illinois, United States Of America).

Tural, D., Karaca, M., Hacioglu, B., Bilgetekin, I., Bilgin, B., Kocoglu, H., ... Ozet, G.(2016). Receptor discordance after neoadjuvant chemotherapy and its impact on disease-free survival. . Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America

Tural, DENİZ Et Al. "Receptor discordance after neoadjuvant chemotherapy and its impact on disease-free survival.," Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 2016

Tural, DENİZ Et Al. "Receptor discordance after neoadjuvant chemotherapy and its impact on disease-free survival.." Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America, 2016

Tural, D. Et Al. (2016) . "Receptor discordance after neoadjuvant chemotherapy and its impact on disease-free survival.." Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America.

@conferencepaper{conferencepaper, author={DENİZ TURAL Et Al. }, title={Receptor discordance after neoadjuvant chemotherapy and its impact on disease-free survival.}, congress name={Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)}, city={Illinois}, country={United States Of America}, year={2016}}